Now that The World Health Organization has issued a full pandemic threat, I find my antennae tuning in to the rapid manufacture and issuance of drugs, vaccines and potential for mass inoculations.
Drug makers have obtained the new influenza A H1N1 seed virus in the past two weeks, enabling them to begin the production process by growing the virus in eggs. http://www.reuters.com/article/mergersNews/idUSWLA645920090611
Swiss pharmaceuticals company Novartis AG http://www.novartis.com/ said today, it has produced a first batch of experimental swine flu vaccine. The vaccine hasn’t yet been tested and cannot be used in humans yet. It was made in cells, rather than grown in eggs as is usually the case with vaccines, the company said. http://www.philstar.com/Article.aspx?articleId=476980&publicationSubCategoryId=200 Damn, that was fast and they didn’t have to use eggs solving a potential problem for those with egg allergens.
Not to be outdone, Sinovac Biotech Company,http://www.sinovac.com/ a vaccine-focused biotech company in China, started efforts to manufacture A/H1N1 influenza vaccine for human use on Monday, after it received the flu strain samples from the WHO, reported Beijing News Tuesday. There are another 10 Chinese drug companies that will obtain the flu strain samples “NYMCX-179A” from the WHO this week. http://english.people.com.cn/90001/90782/90880/6675151.html
It can take five or six months to come up with an entirely novel influenza vaccine,” says John Sterling, Editor in Chief of GEN- Genetic Engineering & Biotechnology News. “There is a great deal of hope that biotech and pharma companies might be able to have something ready sooner.” http://www.genengnews.com/articles/chitem.aspx?aid=2938 In just two weeks he has been proven wrong, as as scientists around the world are accelerating their efforts to develop a vaccine against the H1N1 influenza virus (Swine flu) as rapidly as possible.
Chan from WHO said she would recommend that vaccine manufacturers proceed with mass production of an inoculation against the new swine flu strain as soon as they finish production of seasonal vaccine, which she estimated would be complete in about two weeks. HHS spokesman Bill Hall said Thursday that no decision has been made on full-scale production because there is no need yet to make that decision….. The agency awarded a contract several weeks ago to five manufacturers to develop an H1N1 antigen. The companies are producing pilot lots. Clinical testing will take place over the summer, Hall said. At the end of the summer, HHS will decide whether to go into production. http://entertainment.wagerweb.com/wtf/who-swine-flu-at-stage-6-and-unstoppable-11967.html
Dr. Rambaut says”…the increased detection of mildly deleterious mutations resulting from intensive epidemic surveillance; such mutations would more typically be eliminated and escape detection mutations could be adaptations to the new host species….http://www.nature.com/nature/journal/vnfv/ncurrent/pdf/nature08182.pdf and at his blog http://tree.bio.ed.ac.uk/groups/influenza/
Andrew Rambaut, PhD, of the University of Edinburgh’s Institute of Evolutionary Biology says “These pages exist to enable the rapid dissemination of results resulting from the analysis of genetic data from the ongoing Influenza A/H1N1 outbreak attributed to swine flu. All data used, unless otherwise specified, was made available by GISAID –http://platform.gisaid.org/dante-cms/live/struktur.jdante?aid=1131 or NCBI http://www.ncbi.nlm.nih.gov/ and can be obtained directly from these sites. It is also reviewed at http://www.cidrap.umn.edu/cidrap/content/influenza/swineflu/news/jun1109rambau.html
Citing the world’s best scientists and research- clearly virus mutations can escape detection, have multiple reassortment, have been around for years and contrary to the Pork Industry claims- eight genomic segments of the novel H1N1 have been circulating in swine populations for a number of years, up to 17 years. How they got there,only God knows- at least so far.
More importantly, how could WHO, the CDC, NATO, IMF, WB, Department of HHS, and any other agency order an H1N1 antigen or a vaccine when the scientists are still studying the viruses genetic make up and its mutations? Drug makers just got a virus seed two weeks ago, yet clinical studies will take place in the U.S. this summer? What about the criteria for safety, potency and quality? Will these anticipated clinical testings take place on animals before the initiation of human clinical trials?
Are you willing to stand in line for an untested vaccine against H1N1? Maybe they will develop an oral one that can be mailed via the post office while you are in isolation or quarantine.
“One year ago, a new technology predicted that significant outbreaks of the H1N1 flu virus would occur within 6 to 12 months…Would- not Could! The predictions, made by Replikins, were based on correlations of flu virus specimen and Pub Med documentation of major outbreaks during the past 90 years.” Naturally Replikins’ officials say the company’s PanFLu™ vaccine is ready for clinical trials. Other H1N1 vaccine programs covered in the GEN article include those at Medicago, VaxInnate, NanoBio, Vaxart, Pulmatrix, and Purdue University. Novavax plans to create a virus-like particle-based (VLP) vaccine against the H1N1 strain, which obviates the need for a live virus seed for manufacturing. The VLPs contain the proteins that make the virus’ outer shell and the surface proteins, without the RNA required for replication. props to http://www.medicalnewstoday.com/articles/152456.php
How could these companies have known? How much money are they about to make? How much more money is Obama going seek for a vaccine? Will the vaccine kill more people than the virus as in the previous Swine Flu scare?
Health Secretary Kathleen Sebelius “things could possibly be very different in the fall, especially if things change in the southern hemisphere, and we need to start preparing now in order to be ready for a possible H1N1 immunization campaign starting in late September,” she said.http://news.xinhuanet.com/english/2009-06/12/content_11528978.htm .
This year’s seasonal flu shot http://www.cidrap.umn.edu/cidrap/content/influenza/general/news/feb1309selection-br.html changed one of the three strains used in flu vaccines, keeping the influenza A/H1N1 and A/H3N2 variants used in this year’s vaccine, both of which are labeled Brisbane strains. The influenza B component of this year’s flu vaccine was from the Yamagata lineage. This was decided in February prior to the H1N1 outbreak; how sure are they months later that this year’s annual flu shot will not do more harm than good or encourage viral mutations?
http://www.cdc.gov/flu/weekly/”>http://www.cdc.gov/flu/weekly/ has the flu surveillance report.
Over at the Virology blog http://www.virology.ws/2009/06/09/influenza-virus-toilet/ the author spotted the words ‘Kills Flu Virus’ on a bottle of Clorox toilet bowl cleaner.
Some idiot is going to drink this to prevent the flu; just like they will stand in line to get a flu shot.
Related posts
Open wide, say ahhh and check out these posts on the A/H1N1 Swine Flu from Ahrcanum, where the conspiracy spreads as fast as the virus itself . Our disclaimer-Swine Flu Conspiracy theory can sometimes be triggered by real world events. https://ahrcanum.wordpress.com/swine-flu-report/
Read Full Post »
Every Child By Two (ECBT) was founded by Rosalynn Carter and Betty Bumpers in 1991 as a result of the Measles epidemic that killed over 120 people, many of them children. 
Ahrcanum. Latin origin Arcanus. Mysterious, having special knowledge, information accessible or possesed only by the initiate. Secrets revealed.
Ahrcanum 